Sinuva (mometasone nasal) Drug Interactions

A total of 40 drugs are known to interact with Sinuva (mometasone nasal).

Check for interactions

Type in a drug name to check for interactions with Sinuva (mometasone nasal).

amoxicillin / clarithromycin / lansoprazole (Prevpac)
amoxicillin / clarithromycin / omeprazole (Omeclamox-Pak)
amprenavir (Agenerase)
atazanavir (Reyataz)
atazanavir / cobicistat (Evotaz)
boceprevir (Victrelis)
clarithromycin (Biaxin, Biaxin XL)
cobicistat (Tybost)
cobicistat / darunavir (Prezcobix)
cobicistat / darunavir / emtricitabine / tenofovir alafenamide (Symtuza)
conivaptan (Vaprisol)
darunavir (Prezista)
dasabuvir / ombitasvir / paritaprevir / ritonavir (Viekira Pak, Viekira XR)
delavirdine (Rescriptor)
emtricitabine / lopinavir / ritonavir / tenofovir (AccessPak for HIV PEP Expanded with Kaletra)
emtricitabine / nelfinavir / tenofovir (AccessPak for HIV PEP Expanded with Viracept)
erythromycin (Erythrocin, E-Mycin, EryPed, Ery-Tab, Ilosone, Eryc, Erythrocin Lactobionate, Erythrocin Stearate Filmtab, Robimycin, PCE Dispertab, Wyamycin S, E.E.S. Granules, E.E.S.-200, E.E.S.-400, E.E.S.-400 Filmtab, Erythrocot, MY-E)
erythromycin / sulfisoxazole (Pediazole, Eryzole, Sulfimycin, E S P)
esketamine (Spravato)
fosamprenavir (Lexiva, Telzir)
idelalisib (Zydelig)
indinavir (Crixivan)
itraconazole (Sporanox, Tolsura, Onmel)
ketoconazole (Nizoral)
lopinavir / ritonavir (Kaletra)
mibefradil (Posicor)
miconazole (Oravig)
nefazodone (Serzone)
nelfinavir (Viracept)
ombitasvir / paritaprevir / ritonavir (Technivie)
posaconazole (Noxafil)
ritonavir (Norvir)
saquinavir (Invirase, Fortovase)
stiripentol (Diacomit)
telaprevir (Incivek)
telithromycin (Ketek, Ketek Pak)
troleandomycin (Tao)
voriconazole (Vfend)

There are 5 disease interactions with Sinuva (mometasone nasal) which include:

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major	Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate	Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor	Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown	No interaction information available.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.